Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced key changes in its board and management structure. Dr. Hou Yongtai has been re-elected as Chairman, and Mr. Wu Jianying continues as General Manager, with Ms. Tian Min re-elected as Secretary to the Board and Securities Affairs Representative. These appointments, effective immediately, are part of the company’s strategic efforts to strengthen its governance and operational leadership.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biotechnology sector. It focuses on producing biological products and technologies, with a market focus that includes various medical and healthcare applications.
Average Trading Volume: 698,022
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.93B
Find detailed analytics on 6826 stock on TipRanks’ Stock Analysis page.